论文部分内容阅读
小细胞肺癌(SCLC)病人常发生骨髓转移,文献报道为20~25%,本组为30%。作者对1980年1月至1986年12月期间曾作过骨髓活检的129例 SCLC 病人进行了回顾性分析,判断骨髓转移病人的预后及血生化各项指标的变化对骨髓转移的预测。作者规定,病变局限于一侧肺、纵隔及锁骨上淋巴结为局限性病变;有其他部位转移者为
Patients with small cell lung cancer (SCLC) often have bone marrow metastases, reported in the literature as 20 to 25%, and 30% in this group. The authors performed a retrospective analysis of 129 SCLC patients who had undergone bone marrow biopsy between January 1980 and December 1986, and judged the prognosis of bone marrow metastasis patients and the prediction of bone marrow metastasis by changes in blood biochemical indicators. The authors stipulated that lesions were confined to one lung, mediastinum, and supraclavicular lymph nodes as localized lesions; those with other metastases were